ADE LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$540K Hold
587
0.26% 49
2025
Q4
$631K Sell
587
-52
-8% -$49.7K 0.31% 45
2025
Q3
$488K Buy
639
+378
+145% +$281K 0.25% 53
2025
Q2
$203K Sell
261
-14
-5% -$10.9K 0.11% 77
2025
Q1
$227K Hold
275
0.13% 69
2024
Q4
$212K Buy
275
+16
+6% +$13.2K 0.13% 80
2024
Q3
$229K Hold
259
0.14% 76
2024
Q2
$234K Hold
259
0.16% 75
2024
Q1
$201K Buy
+259
New +$184K 0.14% 79
2021
Q4
Sell
-250
Closed -$58K 159
2021
Q3
$58K Hold
250
0.05% 119
2021
Q2
$57K Buy
+250
New +$50.2K 0.05% 128

Other funds holding LLY

ADE LLC's LLY Position: Q1 2026 in Review

ADE LLC held its Eli Lilly (LLY) position steady in Q1 2026 at 587 shares worth $540K. The position accounts for 0.26% of the portfolio, ranked #49.

ADE LLC first reported a position in LLY in Q2 2021 and has held it in 11 quarters since. The position peaked at $631K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • ADE LLC held 587 shares of Eli Lilly worth $540K as of Q1 2026.
  • ADE LLC left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.26% of ADE LLC's portfolio in Q1 2026, its #49 holding.
  • ADE LLC first reported a position in Eli Lilly in Q2 2021 and has held it in 11 quarters since.
  • ADE LLC's Eli Lilly position peaked at $631K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on ADE LLC's 13F filing for Q1 2026, filed 14 May 2026.